このページの翻訳は実験的なもので、現在開発中です。お待ちしております！
Pediatrix Medical Group マネジメント
マネジメント 基準チェック /34
Pediatrix Medical Group'sの CEO はJim Swiftで、 Jan2023年に任命され、 の在任期間は 1.42年です。 の年間総報酬は$ 2.24Mで、 29%給与と71%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の0.22%を直接所有しており、その価値は$ 1.31M 。経営陣と取締役会の平均在任期間はそれぞれ2.4年と3.9年です。
主要情報
Jim Swift
最高経営責任者
US$2.2m
報酬総額
| CEO給与比率 | 29.0% |
| CEO在任期間 | 1.4yrs |
| CEOの所有権 | 0.2% |
| 経営陣の平均在職期間 | 2.4yrs |
| 取締役会の平均在任期間 | 3.9yrs |
経営陣の近況
Recent updates
Pediatrix Medical Group (NYSE:MD) Has Some Way To Go To Become A Multi-Bagger
May 10
Pediatrix Medical Group, Inc.'s (NYSE:MD) Price Is Right But Growth Is Lacking
Mar 29Pediatrix Medical Group, Inc.'s (NYSE:MD) Intrinsic Value Is Potentially 100% Above Its Share Price
Jan 10Pediatrix Medical Group, Inc.'s (NYSE:MD) Earnings Are Not Doing Enough For Some Investors
Dec 25Is Pediatrix Medical Group (NYSE:MD) A Risky Investment?
Nov 14Is It Time To Consider Buying Pediatrix Medical Group, Inc. (NYSE:MD)?
Oct 13Does Pediatrix Medical Group (NYSE:MD) Have A Healthy Balance Sheet?
Aug 09Pediatrix: Unable To Deploy Capital Tied Up In Cash Conversion Cycle, Reiterate Hold
Aug 08At US$14.21, Is Pediatrix Medical Group, Inc. (NYSE:MD) Worth Looking At Closely?
Jul 03The Returns At Pediatrix Medical Group (NYSE:MD) Aren't Growing
Jun 08Pediatrix Medical Group (NYSE:MD) Has A Somewhat Strained Balance Sheet
Apr 26Is Now An Opportune Moment To Examine Pediatrix Medical Group, Inc. (NYSE:MD)?
Feb 20Pediatrix Medical Group Q4 2022 Earnings Preview
Feb 16Is Pediatrix Medical Group (NYSE:MD) A Risky Investment?
Jan 12Pediatrix: RCM Overhang Now Too Heavy, Revise To Hold
Dec 22Return Trends At Pediatrix Medical Group (NYSE:MD) Aren't Appealing
Dec 20Pediatrix appoints James Swift as chief executive officer
Dec 15Why Pediatrix Medical Group, Inc. (NYSE:MD) Could Be Worth Watching
Nov 05Pediatrix Medical Group GAAP EPS of $0.37 misses by $0.11, revenue of $489.92M misses by $21.54M
Nov 03Pediatrix: These 5 Graphs Suggest It's A Buy
Sep 29Here's Why Pediatrix Medical Group (NYSE:MD) Can Manage Its Debt Responsibly
Sep 13Here's What To Make Of Pediatrix Medical Group's (NYSE:MD) Decelerating Rates Of Return
Aug 29Why Pediatrix Medical Group, Inc. (NYSE:MD) Could Be Worth Watching
Jul 27Pediatrix: Seeking 46% Return Objective As Speculative Buy
Jul 14MEDNAX, Inc. (NYSE:MD) Shares Could Be 47% Below Their Intrinsic Value Estimate
Jun 24MEDNAX (NYSE:MD) Has A Pretty Healthy Balance Sheet
May 25Return Trends At MEDNAX (NYSE:MD) Aren't Appealing
Apr 20MEDNAX, Inc.'s (NYSE:MD) Intrinsic Value Is Potentially 96% Above Its Share Price
Mar 08MEDNAX (NYSE:MD) Seems To Use Debt Quite Sensibly
Feb 15Here's What's Concerning About MEDNAX's (NYSE:MD) Returns On Capital
Jan 19Is MEDNAX, Inc. (NYSE:MD) Trading At A 40% Discount?
Nov 17These 4 Measures Indicate That MEDNAX (NYSE:MD) Is Using Debt Reasonably Well
Oct 23Here's What's Concerning About MEDNAX's (NYSE:MD) Returns On Capital
Oct 08Is MEDNAX (NYSE:MD) A Risky Investment?
Jul 19MEDNAX (NYSE:MD) Could Be Struggling To Allocate Capital
Jun 27Statutory Profit Doesn't Reflect How Good MEDNAX's (NYSE:MD) Earnings Are
May 15Mednax Q1 2021 Earnings Preview
May 06Does MEDNAX (NYSE:MD) Have A Healthy Balance Sheet?
Mar 14CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -US$71m |
| Dec 31 2023 | US$2m | US$650k | -US$60m |
| Sep 30 2023 | n/a | n/a | US$88m |
| Jun 30 2023 | n/a | n/a | US$95m |
| Mar 31 2023 | n/a | n/a | US$98m |
| Dec 31 2022 | US$1m | US$450k | US$63m |
報酬と市場: Jimの 総報酬 ($USD 2.24M ) は、 US市場 ($USD 2.44M ) の同様の規模の企業の平均とほぼ同じです。
報酬と収益: Jimの報酬は増加しましたが、会社は利益を上げていません。
CEO（最高経営責任者
Jim Swift (62 yo)
1.4yrs
在職期間
US$2,237,839
報酬
Dr. James D. Swift, M.D., also known as Jim, is Director of Brave Care, Inc. since October 2021. He had been the Chief Operating Officer at Pediatrix Medical Group, Inc. since May 2022 until December 31, 2...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| CEO & Director | 1.4yrs | US$2.24m | 0.22% $ 1.3m | |
| Executive VP & CFO | 3.8yrs | US$1.78m | 0.27% $ 1.6m | |
| Executive VP & COO | 1.3yrs | US$1.88m | 0.17% $ 1.0m | |
| Executive VP | 1.7yrs | US$1.83m | 0.19% $ 1.2m | |
| Executive Vice President of National & Market Operations | no data | US$1.39m | 0.14% $ 849.1k | |
| Senior VP & Chief Accounting Officer | 8.1yrs | US$1.43m | データなし | |
| Senior VP & Chief Information Officer | 2.4yrs | データなし | データなし | |
| Senior Vice President of Administration & Managed Care | no data | データなし | データなし | |
| Senior VP of Finance | no data | データなし | データなし | |
| Senior VP | 2.8yrs | データなし | データなし | |
| President of Regional Operations (Central) | no data | データなし | データなし | |
| President of Regional Operations (South-Central) | no data | データなし | データなし |
2.4yrs
平均在職期間
61.5yo
平均年齢
経験豊富な経営陣: MDの経営陣は 経験豊富 であると考えられます ( 2.4年の平均在職年数)。
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| CEO & Director | 1.3yrs | US$2.24m | 0.22% $ 1.3m | |
| Chair | 3.9yrs | US$554.45k | 0.20% $ 1.2m | |
| Lead Independent Director | 3.9yrs | US$295.00k | 0.083% $ 494.6k | |
| Independent Director | 3.9yrs | US$252.50k | 0.066% $ 395.7k | |
| Independent Director | 1.1yrs | US$201.00k | 0.035% $ 211.3k | |
| Independent Director | 3.9yrs | US$230.00k | 0.066% $ 395.5k | |
| Independent Director | 3.9yrs | US$245.00k | 0.044% $ 260.9k | |
| Board Observer | 3.9yrs | データなし | データなし | |
| Independent Director | 5.1yrs | US$242.50k | 0.070% $ 421.0k | |
| Independent Director | 2.1yrs | US$230.00k | 0.023% $ 140.8k |
3.9yrs
平均在職期間
61yo
平均年齢
経験豊富なボード: MDの 取締役会 は 経験豊富 であると考えられます ( 3.9年の平均在任期間)。